Yixin Rui

563 citations
7 papers · 416 indexed · 1 hit paper · h-index 4
Topics
Chronic Kidney Disease and Diabetes (3 papers)Berberine and alkaloids research (1 paper)Bioactive Compounds and Antitumor Agents (1 paper)
Partner nations
China

In The Last Decade

Yixin Rui

7 papers receiving 412 citations

Hit Papers

Ferulic acid: A review of its pharmacology, pharmacokinet...20212026202220242021100200300

Peers

Yixin Rui
Comparison fields: 5 of 92
  • Molecular Biology 143
  • Food Science 67
  • Pharmacology 62
  • Plant Science 58
  • Complementary and alternative medicine 57
Replace André Lopes Saraiva with:
André Lopes Saraiva Brazil
Zhili Rao China
Hongfeng Quan China
Yaxuan Sun China
Chulyung Choi South Korea
Bakhta Aouey Tunisia
Cássia Calixto-Campos Brazil
Heba M. I. Abdallah Egypt
Mi-Hyun Nam South Korea
Zhi‐Zhun Mo China
Yixin Rui relative to André Lopes Saraiva Brazil André Lopes Saraiva's profile →
Citations per field
00.5×1.6×
André Lopes Saraiva · 1×
Citations per year

Countries citing papers authored by Yixin Rui

Since Specialization
Citations

This map shows the geographic impact of Yixin Rui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yixin Rui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yixin Rui more than expected).

Fields of papers citing papers by Yixin Rui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yixin Rui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yixin Rui. The network helps show where Yixin Rui may publish in the future.

Co-authorship network of co-authors of Yixin Rui

This figure shows the co-authorship network connecting the top 25 collaborators of Yixin Rui. A scholar is included among the top collaborators of Yixin Rui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yixin Rui. Yixin Rui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 2
2 2
3 2
4 10
5 24
6 42
7
Ferulic acid: A review of its pharmacology, pharmacokinetics and derivativesbreakdown →
334

About Yixin Rui

Yixin Rui is a scholar working on Nephrology, Biological Psychiatry and Toxicology, having authored 7 papers that have together received 416 indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (3 papers), Berberine and alkaloids research (1 paper) and Bioactive Compounds and Antitumor Agents (1 paper). The work is most often cited by research in Biological Psychiatry (31 citations), Biochemistry (49 citations) and Pharmacology (62 citations). Yixin Rui has collaborated with scholars based in China. Frequent co-authors include Nan Zeng, Fei Luan, Rong Liu, Dan Li, Jiuseng Zeng, Yao Liu, Zhili Rao, Rong Liu, Sheng Li and Bo Li. Their work appears in journals such as Journal of Ethnopharmacology, Life Sciences and Frontiers in Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026